Scholarlink

Background <p>Rhomboid intercostal and sub-serratus plane (RISS) block is a novel nerve block technique that provides good analgesia, but overall research is scarce. This study aimed to investigate the effect of ultrasound-guided RISS block on postoperative analgesia and diaphragmatic excursion (DE) after video-assisted thoracic surgery (VATS) for lung cancer.</p> Methods <p>One hundred patients who underwent VATS lung resection participated in this study and were randomized to a RISS group (Group R) or a control group (Group C). Group R underwent ultrasound-guided RISS block with 0.25% ropivacaine hydrochloride 0.5&#xa0;ml/kg immediately after surgery. Group C was given standard general anaesthesia, and patient-controlled intravenous analgesia (PCIA) was used in the postoperative period in both groups. The visual analogue scores (VAS) at rest and during movement at 2&#xa0;hours(h), 24&#xa0;h, and 48&#xa0;h postoperatively were used as the primary outcome measures. Secondary outcomes included postoperative consumption of sufentanil; preoperative and postoperative left and right-sided DE during calm and deep breathing, and the occurrence of adverse effects such as postoperative nausea and vomiting (PONV), dizziness, somnolence, puncture site infection, and hematoma.</p> Results <p>At 2&#xa0;h, 24&#xa0;h, and 48&#xa0;h postoperatively, patients in Group R had lower VAS scores at rest (median [Q1, Q3]: 1.00 [1.00, 1.00]; 1.00 [1.00, 1.00]; 0.00 [0.00, 1.00]) and during movement (2.00 [2.00, 3.00]; 2.00 [2.00, 2.00]; 2.00 [1.00, 2.00]) than those in Group C (resting: 2.00 [2.00, 2.00]; 2.00 [2.00, 2.00]; 1.00 [1.00, 2.00]; movement: 3.00 [3.00, 4.00]; 3.00 [3.00, 4.00]; 3.00 [2.00, 4.00]) (all <i>P</i> &lt; 0.0001). Sufentanil consumption at 2&#xa0;h, 24&#xa0;h, and 48&#xa0;h postoperatively was also significantly lower in Group R (<i>P</i> = 0.0002, <i>P</i> &lt; 0.0001, <i>P</i> &lt; 0.0001). Preoperatively, no significant difference in DE existed between the groups (<i>P</i> &gt; 0.05). At 30&#xa0;min post-extubation and 2&#xa0;h and 24&#xa0;h postoperatively, during both calm and deep breathing on both sides, Group R had significantly greater DE than Group C (<i>P</i> &lt; 0.05). At 48&#xa0;h postoperatively, the right-sided DE during calm breathing showed no significant difference between the groups. PONV incidences did not differ significantly (<i>P</i> = 0.2662), and Group R had less dizziness, somnolence, higher satisfaction post-surgery, and showed no cases of puncture site infection or hematoma.</p> Conclusions <p>Ultrasound-guided RISS block can modestly reduce postoperative pain in patients undergoing VATS, with clinically relevant benefits, and may help alleviate diaphragmatic dysfunction caused by surgical or anesthetic factors.</p> Trial registration <p>The trial was registered at the China Clinical Trial Registry (<a href="http://www.chictr.org.cn">http://www.chictr.org.cn</a>, ChiCTR2300070842) on 24/04/2023.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Effects of rhomboid intercostal and sub-serratus plane block on perioperative analgesic efficacy and diaphragm excursion in video-assisted thoracic surgery: a prospective, randomized controlled trial

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月18日

查看全文
  • Shi-Fei Zhao,
  • Quan-Yuan Chang,
  • Ya-Ru Zheng,
  • Lan Qiu,
  • Jiang Shen

摘要

Background

Rhomboid intercostal and sub-serratus plane (RISS) block is a novel nerve block technique that provides good analgesia, but overall research is scarce. This study aimed to investigate the effect of ultrasound-guided RISS block on postoperative analgesia and diaphragmatic excursion (DE) after video-assisted thoracic surgery (VATS) for lung cancer.

Methods

One hundred patients who underwent VATS lung resection participated in this study and were randomized to a RISS group (Group R) or a control group (Group C). Group R underwent ultrasound-guided RISS block with 0.25% ropivacaine hydrochloride 0.5 ml/kg immediately after surgery. Group C was given standard general anaesthesia, and patient-controlled intravenous analgesia (PCIA) was used in the postoperative period in both groups. The visual analogue scores (VAS) at rest and during movement at 2 hours(h), 24 h, and 48 h postoperatively were used as the primary outcome measures. Secondary outcomes included postoperative consumption of sufentanil; preoperative and postoperative left and right-sided DE during calm and deep breathing, and the occurrence of adverse effects such as postoperative nausea and vomiting (PONV), dizziness, somnolence, puncture site infection, and hematoma.

Results

At 2 h, 24 h, and 48 h postoperatively, patients in Group R had lower VAS scores at rest (median [Q1, Q3]: 1.00 [1.00, 1.00]; 1.00 [1.00, 1.00]; 0.00 [0.00, 1.00]) and during movement (2.00 [2.00, 3.00]; 2.00 [2.00, 2.00]; 2.00 [1.00, 2.00]) than those in Group C (resting: 2.00 [2.00, 2.00]; 2.00 [2.00, 2.00]; 1.00 [1.00, 2.00]; movement: 3.00 [3.00, 4.00]; 3.00 [3.00, 4.00]; 3.00 [2.00, 4.00]) (all P < 0.0001). Sufentanil consumption at 2 h, 24 h, and 48 h postoperatively was also significantly lower in Group R (P = 0.0002, P < 0.0001, P < 0.0001). Preoperatively, no significant difference in DE existed between the groups (P > 0.05). At 30 min post-extubation and 2 h and 24 h postoperatively, during both calm and deep breathing on both sides, Group R had significantly greater DE than Group C (P < 0.05). At 48 h postoperatively, the right-sided DE during calm breathing showed no significant difference between the groups. PONV incidences did not differ significantly (P = 0.2662), and Group R had less dizziness, somnolence, higher satisfaction post-surgery, and showed no cases of puncture site infection or hematoma.

Conclusions

Ultrasound-guided RISS block can modestly reduce postoperative pain in patients undergoing VATS, with clinically relevant benefits, and may help alleviate diaphragmatic dysfunction caused by surgical or anesthetic factors.

Trial registration

The trial was registered at the China Clinical Trial Registry (http://www.chictr.org.cn, ChiCTR2300070842) on 24/04/2023.